In PLOS Genetics, Yale researchers describe germline and somatic mutations identified in individuals with papillary renal cell carcinoma, a form of kidney cancer that remains difficult to treat. Using exome sequence data for nearly 300 papillary renal cell carcinoma cases, along with whole-genome sequences for 35 more individuals with the disease, the team identified alterations affecting new and known papillary renal cell carcinoma contributors.